Capital Ideas publisher Mark Bunting speaks with Lexagene Holdings (TSXV:LXG) CEO Dr. Jack Regan about healthcare and biotech M&A
SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In this episode, Capital Ideas Media publisher Mark Bunting speaks with Dr. Jack Regan, founder and CEO of Lexagene Holdings Inc (TSXV:LXG) (OTC:LXXGF). The Company is on the verge of commercializing its pathogen detection system, which is faster and less expensive than current methods. Regan says Lexagene has already had exploratory talks with larger biotech firms that need this technology in their product line. That makes a buyout of Lexagene later this year a distinct possibility.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
